US2006216331A1PendingUtilityA1

Composition for treating mental health disorders

61
Individually held — no corporate assignee on recordPriority: Feb 28, 2005Filed: Feb 27, 2006Published: Sep 28, 2006
Est. expiryFeb 28, 2025(expired)· nominal 20-yr term from priority
Inventors:Thomas Christian Lines
A61K 36/87A61K 36/00A61P 25/22A23V 2002/00A61K 45/06A61K 36/484A61K 36/16A61K 36/8962A23L 33/105A61K 36/38A61K 36/24A23L 2/52A61P 25/24A61K 31/352A61K 31/05
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition of three compounds each selected from a selective re-uptake inhibitor of serotonin, a monoamine oxidase inhibitor, and a phosphodiesterase inhibitor, such that all three compounds are different and are naturally occurring.

Claims

exact text as granted — not AI-modified
1 . A composition, comprising a first compound, a second compound, and a third compound being a serotonin re-uptake inhibitor, a monoamine oxidase inhibitor, and a phosphodiesterase inhibitor, respectively; wherein the three compounds are different and are naturally occurring.  
     
     
         2 . The composition of  claim 1 , wherein each of the three compounds are selected from the group consisting of glabridin, resveratrol, quercetin and isoquercetin.  
     
     
         3 . The composition of  claim 1 , wherein the serotonin re-uptake inhibitor is glabridin or isoquercetin.  
     
     
         4 . The composition of  claim 1 , wherein the monoamine oxidase inhibitor is glabridin, resveratrol, or quercetin.  
     
     
         5 . The composition of  claim 1 , wherein the phosphodiesterase inhibitor is glabridin or quercetin.  
     
     
         6 . The composition of  claim 1 , wherein the three compounds are provided as plant extracts.  
     
     
         7 . The composition of  claim 1 , wherein the three compounds are provided in pure form.  
     
     
         8 . The composition of  claim 1 , further comprising vitamin C or vitamin B3.  
     
     
         9 . The composition of  claim 2 , wherein glabridin and isoquercetin are provided as a plant extract.  
     
     
         10 . The composition of  claim 2 , wherein resveratrol and quercetin are provided in pure form.  
     
     
         11 . The composition of  claim 2 , further comprising vitamin C or vitamin B3.  
     
     
         12 . The composition of  claim 2 , wherein the composition is in dry form.  
     
     
         13 . The composition of  claim 2 , wherein the composition is tea, juice, soft drink, cookie, cereal, snack bar, chocolate, jelly, ice cream, yogurt, or candy.  
     
     
         14 . The composition of  claim 2 , wherein the composition is a tablet, a tonic, a lozenge, or a spray.  
     
     
         15 . A method of treating depression, comprising administering to a subject in need thereof an effective amount of a composition of  claim 1 .  
     
     
         16 . The method of  claim 15 , wherein the depression is a major depressive disorder, an atypical depression, a bipolar disorder, or a dysthymic disorder.  
     
     
         17 . The method of  claim 15 , wherein the composition is administered orally.  
     
     
         18 . A method of treating anxiety, comprising administering to a subject in need thereof an effective amount of a composition of  claim 1 .  
     
     
         19 . The method of  claim 18 , wherein the anxiety is a panic disorder, a phobia, an obsessive-compulsive disorder, a posttraumatic stress disorder, or a generalized anxiety disorder.  
     
     
         20 . The method of  claim 18 , wherein the composition is administered orally.  
     
     
         21 . A method of treating depression, comprising administering to a subject in need thereof a daily dosage of glabridin 20-3000 mg, a daily dosage of resveratrol 50- 3000 mg, and a daily dosage of quercetin 50-4000 mg.  
     
     
         22 . The method of  claim 21 , wherein the daily dosage of glabridin is 40-2000 mg, the daily dosage of resveratrol is 100-2000 mg, and the daily dosage of quercetin is 100-3000 mg.  
     
     
         23 . The method of  claim 21 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.  
     
     
         24 . A method of treating anxiety, comprising administering to a subject in need thereof a daily dosage of glabridin 20-3000 mg, a daily dosage of resveratrol 50- 3000 mg, and a daily dosage of quercetin 50-4000 mg.  
     
     
         25 . The method of  claim 24 , wherein the daily dosage of glabridin is 20-2000 mg, the daily dosage of resveratrol is 50-2000 mg, and the daily dosage of quercetin is 100-3000 mg.  
     
     
         26 . The method of  claim 24 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.  
     
     
         27 . A method of treating depression, comprising administering to a subject in need thereof a daily dosage of isoquercetin 20-3000 mg, a daily dosage of resveratrol 50-3000 mg, and a daily dosage of quercetin 50-4000 mg.  
     
     
         28 . The method of  claim 27 , wherein the daily dosage of isoquercetin is 40-2000 mg, the daily dosage of resveratrol is 100-2000 mg, and the daily dosage of quercetin is 100-3000 mg.  
     
     
         29 . The method of  claim 27 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.  
     
     
         30 . A method of treating anxiety, comprising administering to a subject in need thereof a daily dosage of isoquercetin 20-3000 mg, a daily dosage of resveratrol 50-3000 mg, and a daily dosage of quercetin 50-4000 mg.  
     
     
         31 . The method of  claim 30 , wherein the daily dosage of isoquercetin is 20-2000 mg, the daily dosage of resveratrol is 50-2000 mg, and the daily dosage of quercetin is 100-3000 mg.  
     
     
         32 . The method of  claim 30 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.  
     
     
         33 . A method of treating depression, comprising administering to a subject in need thereof a daily dosage of glabridin 20-3000 mg, a daily dosage of resveratrol 50-3000 mg, and a daily dosage of isoquercetin 50-4000 mg.  
     
     
         34 . The method of  claim 33 , wherein the daily dosage of glabridin is 20-2000 mg, the daily dosage of resveratrol is 50-2000 mg, and the daily dosage of isoquercetin is 100-3000 mg.  
     
     
         35 . The method of  claim 33 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.  
     
     
         36 . A method of treating anxiety, comprising administering to a subject in need thereof a daily dosage of glabridin 20-3000 mg, a daily dosage of resveratrol 50-3000 mg, and a daily dosage of isoquercetin 50-4000 mg.  
     
     
         37 . The method of  claim 36 , wherein the daily dosage of glabridin is 20-2000 mg, the daily dosage of resveratrol is 50-2000 mg, and the daily dosage of isoquercetin is 100-3000 mg.  
     
     
         38 . The method of  claim 36 , further comprising administering to the subject a daily dosage of vitamin C 20-2000 mg or a daily dosage of vitamin B3 1-200 mg.

Join the waitlist — get patent alerts

Track US2006216331A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.